Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bind Therapeutics (BINDQ)

Bind Therapeutics (BINDQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 3,150
  • Shares Outstanding, K 20,890
  • Annual Sales, $ 15,400 K
  • Annual Income, $ -36,580 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 3.01
  • Price/Sales 0.20
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.87
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/07/16
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/16
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.49
  • Growth Rate Est. (year over year) +203,977.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1202 +20.63%
on 10/05/16
0.6030 -75.95%
on 09/21/16
-0.1460 (-50.17%)
since 09/09/16
3-Month
0.1100 +31.82%
on 09/02/16
1.3200 -89.02%
on 07/27/16
-0.4150 (-74.11%)
since 07/08/16
52-Week
0.1100 +31.82%
on 09/02/16
5.2400 -97.23%
on 11/09/15
-4.3750 (-96.79%)
since 10/09/15

Business Summary

DNIB Unwind, Inc. is a therapeutics company. It developed therapeutics for the treatment of cancer primarily in the United States and Russia. DNIB Unwind, Inc., formerly known as BIND Therapeutics Inc., is based in Cambridge, Massachusetts.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.1703
1st Resistance Point 0.1577
Last Price 0.1450
1st Support Level 0.1337
2nd Support Level 0.1223
3rd Support Level N/A

See More

52-Week High 5.2400
Fibonacci 61.8% 3.2803
Fibonacci 50% 2.6750
Fibonacci 38.2% 2.0697
Last Price 0.1450
52-Week Low 0.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.